Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sordillo PP et al. | Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. | In Vivo | pmid:26546519 | |
Fournie P et al. | Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. | 2012 Mar-Apr | Indian J Ophthalmol | pmid:22446906 |
Farnoud AM et al. | The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway. | 2015 | Infect. Immun. | pmid:25895971 |
Miyabe C et al. | A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis. | 2017 | Inflamm. Res. | pmid:27942751 |
Lv M et al. | Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion. | 2016 | Inflamm. Res. | pmid:27002656 |
Seo Y et al. | Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy. | 2017 | Inflamm. Res. | pmid:28364200 |
Ding R et al. | Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase. | 2012 | Inflammation | pmid:21302134 |
Yu H et al. | Sphingosine kinase 1 improves cutaneous wound healing in diabetic rats. | 2014 | Injury | pmid:24685054 |
BÅ‚ogowski W et al. | Perioperative release of pro-regenerative biochemical signals from human renal allografts subjected to ischemia-reperfusion injury. | 2014 | Innate Immun | pmid:23608824 |
Pan HY et al. | Sphingosine-1-phosphate mediates AKT/ERK maintenance of dental pulp homoeostasis. | 2015 | Int Endod J | pmid:24931601 |
Tian H and Yu Z | Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway. | 2015 | Int J Clin Exp Pathol | pmid:26045781 |
Sali M et al. | Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection. | 2009 Jan-Mar | Int J Immunopathol Pharmacol | pmid:19309565 |
Tokumura A et al. | Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. | 2009 | Int J Med Sci | pmid:19521548 |
Ueda N | Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate. | 2015 | Int J Mol Sci | pmid:25751724 |
Smith P et al. | Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. | 2017 | Int J Mol Sci | pmid:28934113 |
Haddadi N et al. | "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer. | 2017 | Int J Mol Sci | pmid:28869494 |
Egom EE et al. | Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry. | 2017 | Int J Mol Sci | pmid:28820460 |
Hajny S and Christoffersen C | A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. | 2017 | Int J Mol Sci | pmid:28749426 |
Koch A et al. | Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients. | 2017 | Int J Mol Sci | pmid:28714882 |
Wollny T et al. | Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease. | 2017 | Int J Mol Sci | pmid:28362332 |
Costello RW et al. | Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells. | 2011 | Int J Mol Sci | pmid:21686182 |
Gil-Ortega M et al. | Ex vivo microperfusion system of the adipose organ: a new approach to studying the mobilization of adipose cell populations. | 2014 | Int J Obes (Lond) | pmid:24357852 |
Masuko K et al. | Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. | 2012 | Int J Rheum Dis | pmid:22898216 |
Baranowski M et al. | Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration. | 2014 | Int J Sport Nutr Exerc Metab | pmid:24092763 |
Beyer T and Meyer-Hermann M | Mechanisms of organogenesis of primary lymphoid follicles. | 2008 | Int. Immunol. | pmid:18334502 |
Jung ID et al. | Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells. | 2007 | Int. Immunol. | pmid:17307797 |
Maeda Y et al. | S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1. | 2014 | Int. Immunol. | pmid:24343820 |
Setoguchi R | IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. | 2016 | Int. Immunol. | pmid:26857736 |
Maeda Y et al. | Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. | 2010 | Int. Immunol. | pmid:20497959 |
Korbelik M et al. | Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. | 2014 | Int. Immunopharmacol. | pmid:24713544 |
Zebol JR et al. | The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1. | 2009 | Int. J. Biochem. Cell Biol. | pmid:18775504 |
Wang S et al. | A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression. | 2012 | Int. J. Biol. Macromol. | pmid:22197795 |
Ohotski J et al. | Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. | 2013 | Int. J. Cancer | pmid:22733311 |
Beckham TH et al. | Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. | 2012 | Int. J. Cancer | pmid:22322590 |
Weigert A et al. | Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. | 2009 | Int. J. Cancer | pmid:19618460 |
Polzin A et al. | Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. | 2013 | Int. J. Cardiol. | pmid:24169533 |
Lee KP et al. | DJ-1-mediated upregulation of serine palmitoyltransferase 2 controls vascular neointima via S1P autocrine. | 2015 | Int. J. Cardiol. | pmid:25978603 |
Sobue S et al. | Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells. | 2008 | Int. J. Hematol. | pmid:18283525 |
Ng ML et al. | The role of sphingolipid signalling in diabetes‑associated pathologies (Review). | 2017 | Int. J. Mol. Med. | pmid:28075451 |
Moon MH et al. | Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. | 2012 | Int. J. Mol. Med. | pmid:22992945 |
Renkl A et al. | Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. | 2004 | Int. J. Mol. Med. | pmid:14719124 |
Lim J et al. | Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells. | 2017 | Int. J. Mol. Med. | pmid:28677769 |
Chen W et al. | Sphingosine 1-phosphate in metabolic syndrome (Review). | 2016 | Int. J. Mol. Med. | pmid:27600830 |
Minamitani C et al. | Involvement of Rho-kinase in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. | 2009 | Int. J. Mol. Med. | pmid:19513538 |
Natsume H et al. | (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts. | 2009 | Int. J. Mol. Med. | pmid:19578793 |
Ishitsuka A et al. | FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. | 2014 | Int. J. Mol. Med. | pmid:25109763 |
Moon MH et al. | Sphingosine-1-phosphate inhibits the adipogenic differentiation of 3T3-L1 preadipocytes. | 2014 | Int. J. Mol. Med. | pmid:25050633 |
Lee YJ et al. | Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling. | 2013 | Int. J. Mol. Med. | pmid:23381659 |
Lagadari M et al. | Sphingosine-1-phosphate inhibits the cytotoxic activity of NK cells via Gs protein-mediated signalling. | 2009 | Int. J. Oncol. | pmid:19082500 |
Hsu A et al. | Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. | 2012 | Int. J. Oncol. | pmid:22344462 |
Won J and Lee GH | T-cell-targeted signaling inhibitors. | 2008 Jan-Apr | Int. Rev. Immunol. | pmid:18300054 |
Babahosseini H et al. | Bioactive sphingolipid metabolites modulate ovarian cancer cell structural mechanics. | 2013 | Integr Biol (Camb) | pmid:24056950 |
Salmanzadeh A et al. | Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model. | 2013 | Integr Biol (Camb) | pmid:23609351 |
Lim SH et al. | Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting. | 2013 | Integr Biol (Camb) | pmid:24190477 |
Ling B et al. | Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer. | 2011 | Invest New Drugs | pmid:20041340 |
Boussommier-Calleja A et al. | Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. | 2012 | Invest. Ophthalmol. Vis. Sci. | pmid:22807298 |
Miranda GE et al. | Sphingosine-1-phosphate is a key regulator of proliferation and differentiation in retina photoreceptors. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19357361 |
Kim SE et al. | The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy. | 2016 | Invest. Ophthalmol. Vis. Sci. | pmid:26830367 |
Wang J et al. | Receptor-mediated activation of a Cl(-) current by LPA and S1P in cultured corneal keratocytes. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:12356825 |
Qiao Y et al. | Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. | 2012 | Invest. Ophthalmol. Vis. Sci. | pmid:23150617 |
Simón MV et al. | Sphingosine-1-Phosphate Is a Crucial Signal for Migration of Retina Müller Glial Cells. | 2015 | Invest. Ophthalmol. Vis. Sci. | pmid:26325420 |
Yin F and Watsky MA | LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance. | 2005 | Invest. Ophthalmol. Vis. Sci. | pmid:15914605 |
Abrahan CE et al. | Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:19797232 |
Sumida GM and Stamer WD | Sphingosine-1-phosphate enhancement of cortical actomyosin organization in cultured human Schlemm's canal endothelial cell monolayers. | 2010 | Invest. Ophthalmol. Vis. Sci. | pmid:20592229 |
Ko J et al. | Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy. | 2017 | Invest. Ophthalmol. Vis. Sci. | pmid:28492873 |
Aoyama-Araki Y et al. | Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma. | 2017 | Invest. Ophthalmol. Vis. Sci. | pmid:28418499 |
Durham JT et al. | Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy? | 2015 | Invest. Ophthalmol. Vis. Sci. | pmid:26030100 |
Lee H et al. | 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. | 2013 May-Jun | Islets | pmid:23756681 |
Sabbadini RA et al. | The role of sphingolipids in the control of skeletal muscle function: a review. | 1999 | Ital J Neurol Sci | pmid:10937863 |
Meacci E et al. | Sphingosine 1-phosphate signal transduction in muscle cells. | 2003 | Ital. J. Biochem. | pmid:12833634 |
Leclercq TM and Pitson SM | Cellular signalling by sphingosine kinase and sphingosine 1-phosphate. | 2006 | IUBMB Life | pmid:16916784 |
GarcÃa-Sáinz JA et al. | Mechanisms involved in α1B-adrenoceptor desensitization. | 2011 | IUBMB Life | pmid:21815242 |
Chawla S et al. | S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report. | 2016 | IUBMB Life | pmid:26959531 |
Siess W et al. | Lysophosphatidic acid and sphingosine 1-phosphate: two lipid villains provoking cardiovascular diseases? | 2000 | IUBMB Life | pmid:10868905 |
Kim JH et al. | Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells. | 2000 | IUBMB Life | pmid:11185956 |
Marycz K et al. | The influence of metal-based biomaterials functionalized with sphingosine-1-phosphate on the cellular response and osteogenic differentaion potenial of human adipose derived mesenchymal stem cells in vitro. | 2016 | J Biomater Appl | pmid:26801473 |
Alford SK et al. | Endothelial cell migration in human plasma is enhanced by a narrow range of added sphingosine 1-phosphate: implications for biomaterials design. | 2009 | J Biomed Mater Res A | pmid:18286622 |
Kim YH and Tabata Y | Recruitment of mesenchymal stem cells and macrophages by dual release of stromal cell-derived factor-1 and a macrophage recruitment agent enhances wound closure. | 2016 | J Biomed Mater Res A | pmid:26704185 |
Southern C et al. | Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. | 2013 | J Biomol Screen | pmid:23396314 |
Wetter JA et al. | Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. | 2009 | J Biomol Screen | pmid:19726785 |
Highkin MK et al. | High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. | 2011 | J Biomol Screen | pmid:21297110 |
Niedernberg A et al. | Comparative analysis of functional assays for characterization of agonist ligands at G protein-coupled receptors. | 2003 | J Biomol Screen | pmid:14567777 |
Tabasinezhad M et al. | Sphingosin 1-phosphate contributes in tumor progression. | J Cancer Res Ther | pmid:24518696 | |
Egom EE | Sphingosine-1-phosphate signalling as a therapeutic target for patients with abnormal glucose metabolism and ischaemic heart disease. | 2014 | J Cardiovasc Med (Hagerstown) | pmid:23839592 |
Rohatagi S et al. | Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator. | 2009 | J Clin Pharmacol | pmid:18948412 |
Kurek K et al. | Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance. | 2015 | J Diabetes Res | pmid:26380311 |
Howard C et al. | Dental pulp stem cell migration. | 2010 | J Endod | pmid:21092813 |
Komatsu I et al. | Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II. | 2010 | J Hand Surg Am | pmid:20888494 |
Rokka J et al. | 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical. | 2013 | J Labelled Comp Radiopharm | pmid:24285478 |
Spiegel S | Sphingosine and sphingosine 1-phosphate in cellular proliferation: relationship with protein kinase C and phosphatidic acid. | 1993 | J Lipid Mediat | pmid:8268463 |
Nagahashi M et al. | Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods. | 2016 | J Mammary Gland Biol Neoplasia | pmid:27194029 |
He X et al. | Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. | 2010 | J Mol Cell Biol | pmid:20584786 |
Dong T et al. | Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. | 2016 | J Neuroinflammation | pmid:27561600 |
Kułakowska A et al. | Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis. | 2014 | J Neuroinflammation | pmid:25421616 |
Hoffmann FS et al. | Fingolimod induces neuroprotective factors in human astrocytes. | 2015 | J Neuroinflammation | pmid:26419927 |
Li C et al. | Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3. | 2015 | J Neuroinflammation | pmid:25880547 |
Rhee SH et al. | Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. | 2015 | J Obstet Gynaecol | pmid:25692679 |
Rao PV | Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. | 2014 Mar-Apr | J Ocul Pharmacol Ther | pmid:24283588 |
Takeshita A et al. | Sphingosine 1-phosphate acts as a signal molecule in ceramide signal transduction of TNF-alpha-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells. | 2005 | J Oral Sci | pmid:15881228 |
Navarrete A et al. | A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema. | 2017 | J Pharm Biomed Anal | pmid:28314215 |